Medicare Enrolled

Dr. Lucas Mikulic, MD

Pulmonary Disease · Clearwater, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
430 MORTON PLANT STREET, Clearwater, FL 33756
7274430611
In practice since 2007 (18 years)
NPI: 1093998742 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mikulic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mikulic? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mikulic

Dr. Lucas Mikulic is a pulmonary disease in Clearwater, FL, with 18 years in practice. Based on federal Medicare data, Dr. Mikulic performed 1,484 Medicare services across 1,024 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mikulic received a total of $3,592 from 38 pharmaceutical and/or device companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mikulic is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 41% volume in FL$ $3,592 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,484
Medicare services
Top 41% in FL for pulmonary disease
1,024
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Critical care, first 30-74 min315$170$535
Hospital follow-up visit, high complexity297$92$280
Office visit, established patient (30-39 min)172$85$161
Office visit, established patient, complex (40-54 min)118$135$215
Hospital follow-up visit, moderate complexity115$62$186
Initial hospital admission, high complexity104$135$434
Test to examine how well the lungs exchange gases71$40$92
Test to determine lung volumes using sensors70$40$90
Test to measure expiratory airflow and volume changes before and after medication administration59$28$94
Test for exercise-induced lung stress35$26$68
New patient office visit, complex (60-74 min)35$172$309
Test to determine lung volumes using gas dilution or washout26$9$30
Initial hospital admission, moderate complexity15$103$433
Evaluation of use of breathing device14$12$27
Critical care, each additional 30 minutes14$86$433
Test to measure expiratory airflow and volume13$21$55
Test to measure the level of nitric oxide gas11$14$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,592
Total received (2018-2024)
Avg $513/year across 7 years
Top 46% in FL for pulmonary disease
38
Companies
187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,592 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$957
2023
$826
2022
$246
2021
$115
2020
$396
2019
$587
2018
$466

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$421
GlaxoSmithKline, LLC.
$381
Boehringer Ingelheim Pharmaceuticals, Inc.
$341
Insmed, Inc.
$314
Actelion Pharmaceuticals US, Inc.
$250
Amgen Inc.
$210
Regeneron Healthcare Solutions, Inc.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$148
United Therapeutics Corporation
$114
Mylan Specialty L.P.
$93
Merck Sharp & Dohme LLC
$87
GENZYME CORPORATION
$81
Genentech USA, Inc.
$78
Inspire Medical Systems, Inc.
$77
Electromed, Inc.
$69
PORTOLA PHARMACEUTICALS, INC.
$69
Circassia Pharmaceuticals Inc
$68
Sunovion Pharmaceuticals Inc.
$68
Vapotherm Inc
$67
Bayer HealthCare Pharmaceuticals Inc.
$53
Bayer Healthcare Pharmaceuticals Inc.
$47
ABBVIE INC.
$46
Ethicon Inc.
$43
PFIZER INC.
$38
Grifols USA, LLC
$38
Novartis Pharmaceuticals Corporation
$28
Shionogi Inc
$24
Harmony Biosciences LLC
$22
Mallinckrodt LLC
$21
Shire North American Group Inc
$20
Eisai Inc.
$20
Gilead Sciences, Inc.
$18
Jazz Pharmaceuticals Inc.
$17
CSL Behring
$16
Allergan Inc.
$16
Philips Electronics North America Corporation
$13
Theravance Biopharma, Inc.
$12
INOGEN, INC.
$4
Top 3 companies account for 31.8% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · BEVYXXA · BREZTRI · DUPIXENT · Dayvigo · Dymista · Esbriet · FASENRA · Fetroja · GLASSIA · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · Kcentra · LOKELMA · MONARCH · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · PREVNAR 20 · Prolastin-C Liquid · REMODULIN · SEEBRI · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON · VAPOTHERM · VIBATIV · WAKIX · WINREVAIR · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $242 per 100 Medicare services performed
Looking for a pulmonary disease in Clearwater?
Compare pulmonary diseases in the Clearwater area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
89
Per 100K population
9.3
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mikulic is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mikulic experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Mikulic performed 315 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mikulic receive payments from pharmaceutical companies?
Yes. Dr. Mikulic received a total of $3,592 from 38 companies across 187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mikulic's costs compare to other pulmonary diseases in Clearwater?
Dr. Mikulic's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mikulic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →